ANNOUNCEMENT: partnership with Nichirei Biosciences to supply Japanese market

ANNOUNCEMENT: partnership with Nichirei Biosciences to supply Japanese market

UPM Biomedicals is partnering with Nichirei Biosciences Inc. to offer the full range of UPM cell culture products to life sciences researchers in Japan. This agreement will provide the country’s cell biology community with direct access to UPM’s GrowDex® hydrogels for the first time, supporting advanced cell culture and stem cell biology applications.

The GrowDex range of natural hydrogels mimics the extracellular matrix (ECM) to support cell growth and differentiation for more consistent, biologically-relevant results. This animal-free, ready to use system is the perfect complement to Nichirei Biosciences’ existing product portfolio, helping to bridge the gap between in vitro and in vivo studies by allowing the formation of 3D cell spheroids/organoids for personalised medicine, regenerative medicine, organ-on-a-chip models, drug release studies, etc.

Dr Jane Spencer-Fry, Director at UPM Biomedicals, commented: “Our animal-free cell culture products are ideal for the cutting-edge cell biology research currently being undertaken in Japan – the home of induced pluripotent stem cells. Our agreement with Nichirei Biosciences will provide customers with access to these products with the full support of a knowledgeable local supplier, helping to further advance their high quality research efforts.”

VWR, Part of Avantor

Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Ireland, Northern Ireland, Italy, The Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, United Kingdom

Carl Zeiss LLC

Moscow. Saint-Petersburg, Novosibirsk, Ekaterinburg, Krasnodar, Kazan. Nizhniy Novgorod, Vladivostok. Kyiv, Almaty, Belarus. Georgia. Azerbaijan, Armenia, Uzbekistan, Moldova

South Korea
i-DNA Biotechnology

Singapore, Malaysia, Vietnam
AXOL Bioscience

Nichirei Biosciences Inc.     www.nichirei.co.jp Japan